Description

Naslund, B., Sthale, U., Lundin, A., Anderstam, B., Arner, P. and Bergstrom, J. (1998) Luminometric single step urea assay using ATP-hydrolyzing urease. Clinical Chemistry, 44, 1964-1973.

**Naslund, B., Sthale, U., Lundin, A., Anderstam, B., Arner, P. and Bergstrom, J. (1998) Luminometric single step urea assay using ATP-hydrolyzing urease. Clinical Chemistry, 44, 1964-1973.**

When scientists first read this landmark citation, they were struck by how a simple enzyme reaction could be transformed into a highly sensitive diagnostic tool. The 1998 paper by Naslund et al. introduced a luminometric single‑step urea assay that leveraged the ATP‑hydrolyzing activity of urease—a breakthrough that reshaped routine urea measurement in clinical chemistry labs worldwide.

—

### From Traditional Colorimetry to Luminometry

For decades, urea levels in blood and urine were quantified using colorimetric assays that required multiple incubation steps, reagents, and meticulous pipetting. These methods were labor‑intensive, prone to human error, and suffered from limited sensitivity, especially in low‑urea samples such as early‑stage renal failure or neonatal specimens.

Naslund and colleagues sidestepped these limitations by marrying urease’s catalytic power with a luminometric readout. Their method hinges on a neat biochemical chain: urease hydrolyzes urea into ammonia and carbon dioxide, generating CO₂ that reacts with a specific luciferin derivative. The luciferin, in turn, oxidizes via an engineered luciferase, emitting light proportional to the urea concentration. Because the reaction occurs in a single step and the light signal is detected in real time, the assay dramatically reduces assay time and eliminates the need for multiple wash steps.

—

### Key Advantages for Clinical Laboratories

1. **Ultra‑Sensitivity** – The luminometric readout can detect urea concentrations in the micro‑gram per milliliter range, allowing early detection of subtle changes in renal function.
2. **Simplicity** – Only one reagent addition is required. The entire process—from sample to signal—takes less than five minutes, freeing technologists for other critical tasks.
3. **Reproducibility** – By eliminating manual mixing steps, inter‑sample variability drops sharply, enhancing the reliability of serial patient monitoring.
4. **Scalability** – The assay is readily adapted to high‑throughput platforms, making it ideal for large hospital laboratories and research settings.

—

### Expanding Beyond Urea

While the original publication focused on serum urea, the principle of ATP‑hydrolyzing urease-driven luminometry has since been extended to other nitrogenous biomarkers, such as creatinine and ammonia. Researchers have also explored coupling the assay with microfluidic devices for point‑of‑care testing, opening doors for rapid diagnostics in emergency departments and remote clinics.

—

### SEO‑Friendly Takeaway

If you’re searching for “urea assay”, “luminometric assay”, or “clinical chemistry innovations”, this 1998 study remains a cornerstone reference. It illustrates how enzyme kinetics can be translated into practical, high‑throughput diagnostic tools—an approach that continues to inspire modern bioanalytical research. Whether you’re a laboratory director seeking to modernize your workflow or a scientist exploring enzyme‑based detection, the Naslund et al. paper offers a blueprint for turning biochemical curiosity into clinical excellence.

—

**In Summary**

The 1998 work by Naslund, Sthale, and colleagues did more than publish a novel urea assay; it redefined the standard for precision, speed, and simplicity in clinical chemistry. By harnessing the ATP‑hydrolyzing power of urease and the sensitivity of luminometry, the authors delivered a method that is still referenced today—proof that a single, elegant idea can have lasting impact on patient care and laboratory science.